Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate

References

• Olesen J, Ashina M. Emerging migraine treatments and drug targets. Trends Pharmacol Sci 2011;32:352–9.
   PubMed Web of Science ®Google Scholar
• Cull RE, Price WH, Dunbar A. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. J Neurol Neurosurg Psychiatry 1997;62:490–5.
   PubMed Web of Science ®Google Scholar
• Dixon CM, Park GR, Tarbit MH. Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver. Biochem Pharmacol 1994;47:1253–7.
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668–75.
   PubMed Web of Science ®Google Scholar
• Hardebo JE, Dahlöf C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache. Cephalalgia 1998;18:487–9.
   PubMed Web of Science ®Google Scholar
• Lacey LF, Hussey EK, Fowler PA. Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur J Clin Pharmacol 1995;47:543–8.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 1998;18:532–8.
   PubMed Web of Science ®Google Scholar
• Alexander A, Dwivedi S, Ajazuddin, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012;164:26–40.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008;26:1261–8.
   PubMed Web of Science ®Google Scholar
• Femenía-Font A, Balaguer-Fernández C, Merino V, et al. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 2005;61:50–5.
   PubMed Web of Science ®Google Scholar
• Wu D, Tanaka Y, Jin YR, et al. Development of a novel transdermal patch containing sumatriptan succinate for the treatment of migraine: in vitro and in vivo characterization. J Drug Deliv Sci Tech 2014;24:695–701.
   Web of Science ®Google Scholar
• Garnock-Jones KP. Sumatriptan iontophoretic transdermal system: a review of its use in patients with acute migraine. Drugs 2013;73:1483–90.
   PubMed Web of Science ®Google Scholar
• Pierce M, Marbury T, O’Neill C, et al. Zelrix: a novel transdermal formulation of sumatriptan. Headache 2009;49:817–25.
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012;64:1547–68.
   PubMed Web of Science ®Google Scholar
• Sachdeva V, Banga AK. Microneedles and their applications. Recent Pat Drug Deliv Formul 2011;5:95–132.
   PubMedGoogle Scholar
• Tuan-Mahmood TM, McCrudden MT, Torrisi BM, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci 2013;50:623–37.
   PubMed Web of Science ®Google Scholar
• Ito Y, Hirono M, Fukushima K, et al. Two-layered dissolving microneedles formulated with intermediate-acting insulin. Int J Pharm 2012;436:387–93.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, et al. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 2011;28:135–44.
   PubMed Web of Science ®Google Scholar
• Oh JH, Park HH, Do KY, et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm 2008;69:1040–5.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xu B, Gao Y. Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine 2005;1:184–90.
   PubMed Web of Science ®Google Scholar
• Yan G, Warner KS, Zhang J, et al. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm 2010;391:7–12.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhu H, Zheng J, et al. Iontophoresis-driven penetration of nanovesicles through microneedle induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release 2009;139:63–72.
   PubMed Web of Science ®Google Scholar
• Pearton M, Saller V, Coulman SA, et al. Microneedle delivery of plasmid DNA to living human skin: formulation coating, skin insertion and gene expression. J Control Release 2012;160:561–9.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Gao Y, Hu K, Li F. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release 2008;129:144–50.
   PubMed Web of Science ®Google Scholar
• Martanto W, Moore JS, Kashlan O, et al. Microinfusion using hollow microneedles. Pharm Res 2006;23:104–13.
   PubMed Web of Science ®Google Scholar
• Gomaa YA, Garland MJ, McInnes F, et al. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Eur J Pharm Biopharm 2012;82:299–307.
   PubMed Web of Science ®Google Scholar
• Jin CY, Han MH, Lee SS, Choi YH. Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery. Biomed Microdevices 2009;11:1195–203.
   PubMed Web of Science ®Google Scholar
• McCrudden MTC, Alkilani AZ, McCrudden CM, et al. Design and physicochemical characterization of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release 2014;180:71–80.
   PubMed Web of Science ®Google Scholar
• Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005;104:51–66.
   PubMed Web of Science ®Google Scholar
• Kolli CS, Banga AK. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 2008;25:104–13.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008;29:2113–24.
   PubMed Web of Science ®Google Scholar
• Li GH, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 2009;368:109–15.
   PubMed Web of Science ®Google Scholar
• Liu S, Jin MN, Quan YS, et al. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release 2012;161:933–41.
   PubMed Web of Science ®Google Scholar
• Wu D, Quan YS, Kamiyama F, et al. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats. Biol Pharm Bull 2015;38:365–73.
   PubMed Web of Science ®Google Scholar
• Katsumi H, Liu S, Tanaka Y, et al. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. J Pharm Sci 2012;101:3230–8.
   PubMed Web of Science ®Google Scholar
• Liu S, Jin MN, Quan YS, et al. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur J Pharm Biopharm 2014;86:267–76.
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1994;82:377–90.
   Google Scholar
• Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 1982;62:481–8.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Garland MJ, Morrow DIJ, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release 2010;147:333–41.
   PubMed Web of Science ®Google Scholar
• Garland MJ, Migalska K, Tuan-Mahmood TM, et al. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm 2012;434:80–9.
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Takasuga S, Yoshida Y, et al. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. Int J Pharm 2012;422:132–8.
   PubMed Web of Science ®Google Scholar